Evidence map›Paper›PMID 25222118›Full record

ArticlePloS one2014

A high-throughput gene disruption methodology for the entomopathogenic fungus Metarhizium robertsii.

Chuan Xu, Xing Zhang, Ying Qian, Xiaoxuan Chen, Ran Liu, Guohong Zeng, Hong Zhao, Weiguo Fang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Mr-lac3 and Mr-lcc2 inJournal of fungi (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Characterization of regulatory genesFrontiers in microbiology · 2024
    Article
  7. Ethanol mediates the interaction betweenMicrobiology spectrum · 2023
    Article
  8. Article
  9. The Growth and Conidiation ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Bioremediation of mercury-polluted soil and water by the plant symbiotic fungusProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Updates inJournal of fungi (Basel, Switzerland) · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chuan XuInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Xing ZhangInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Ying QianInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Xiaoxuan ChenInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Ran LiuInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Guohong ZengInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Hong ZhaoInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Weiguo FangInstitute of Microbiology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systematic gene disruption is a direct way to interrogate a fungal genome to functionally characterize the full suite of genes involved in various biological processes. Metarhizium robertsii is extraordinarily versatile, and it is a pathogen of arthropods, a saprophyte and a beneficial colonizer of rhizospheres. Thus, M. robertsii can be used as a representative to simultaneously study several major lifestyles that are not shared by the "model" fungi Saccharomyces cerevisiae and Neurospora crassa; a systematic genetic analysis of M. robertsii will benefit studies in other fungi. In order to systematically disrupt genes in M. robertsii, we developed a high-throughput gene disruption methodology, which includes two technologies. One is the modified OSCAR-based, high-throughput construction of gene disruption plasmids. This technology involves two donor plasmids (pA-Bar-OSCAR with the herbicide resistance genes Bar and pA-Sur-OSCAR with another herbicide resistance gene Sur) and a recipient binary plasmid pPK2-OSCAR-GFP that was produced by replacing the Bar cassette in pPK2-bar-GFP with a ccdB cassette and recombination recognition sites. Using this technology, a gene disruption plasmid can be constructed in one cloning step in two days. The other is a highly efficient gene disruption technology based on homologous recombination using a Ku70 deletion mutant (ΔMrKu70) as the recipient strain. The deletion of MrKu70, a gene encoding a key component involved in nonhomologous end-joining DNA repair in fungi, dramatically increases the gene disruption efficiency. The frequency of disrupting the conidiation-associated gene Cag8 in ΔMrKu70 was 93% compared to 7% in the wild-type strain. Since ΔMrKu70 is not different from the wild-type strain in development, pathogenicity and tolerance to various abiotic stresses, it can be used as a recipient strain for a systematic gene disruption project to characterize the whole suite of genes involved in the biological processes of M. robertsii.

Indexed as

Genome, FungalAntigens, NuclearDNA-Binding ProteinsDNA End-Joining RepairGenotypeKu AutoantigenMetarhiziumNeurospora crassaPlasmidsSaccharomyces cerevisiaeSpores, FungalAntigens, NuclearDNA-Binding ProteinsKu Autoantigen

Identifiers

PMID25222118
PMCPMC4164657
OpenAlexW1983236655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.